...
【24h】

Preface

机译:前言

获取原文
获取原文并翻译 | 示例
           

摘要

As the Editor-in-Chief of "Current Drug Research Reviews" (CDRR, online ISSN: 2589-9783, print ISSN: 2589-9775; formerly Current Drug Abuse Reviews), a peer-reviewed journal, I wish a warm welcome to all the readers to this new volume. CDRR is an international peer-reviewed journal, which publishes research articles, review articles and clinical studies on the design and development of new drugs, including drug targeting, medicinal chemistry, in silico drug design, combinatorial chemistry, meta-analyses, drug abuse and addiction, drug-drug interactions and enzyme kinetics; species scaling and extrapolations; drug transporters; target organ toxicity and inter-individual variability in drug exposure-response; extrahepatic metabolism; bio-activation, reactive metabolites, high-throughput screening, drug targets and structure-activity relationships. The journal aims to cover the latest developments in all important aspects of drug design, delivery, development and research.
机译:主编的“当前药物研究网上评论”(CDRR ISSN: 2589 - 9783年,打印石头:2589 - 9775;评论),同行评议的杂志,我希望一个温暖欢迎所有读者这个新卷。CDRR是一个国际期刊上发表过,出版研究文章,评论在设计和文章和临床研究开发新的药物,包括药物目标,药物化学,在硅片的药物设计,组合化学,荟萃分析,药物滥用和成瘾、药物之间的相互作用和酶动力学;推断;药物的毒性和inter-individual可变性我们;bio-activation活性代谢物,高通量筛选、药物靶点结构活性关系。旨在覆盖所有的最新发展药物设计的重要方面,交付,开发和研究。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号